Initial combination therapy with sitagliptin, a dipeptidyl peptidase-4 inhibitor, and metformin for patients with Type 2 diabetes mellitus.
This article reviews initial treatment with Janumet as an alternative to monotherapy.
PMID: 30743780 [PubMed]
Source: Expert Review of Endocrinology and Metabolism - Category: Endocrinology Tags: Expert Rev Endocrinol Metab Source Type: research
More News: Diabetes | Diabetes Mellitus | Diabetes Type 2 | Endocrinology | Fortamet | Hormones | Incretin Therapy | Insulin | Janumet | Januvia | Metformin | Nutrition